What is the proper dosage and administration of adrenalin (epinephrine) in emergency situations?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 29, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Adrenaline (Epinephrine) Dosing and Administration in Emergency Situations

For anaphylaxis, administer 0.3-0.5 mg (0.3-0.5 mL of 1:1000 concentration) intramuscularly into the anterolateral thigh, repeating every 5-15 minutes as needed; for cardiac arrest, give 1 mg IV/IO (1:10,000 concentration) every 3-5 minutes. 1, 2

Anaphylaxis Management

The intramuscular route into the lateral thigh is the preferred initial approach because it provides rapid peak plasma concentrations, is easy to administer, and has superior safety compared to IV administration. 2, 1

Adult Dosing for Anaphylaxis

  • Initial dose: 0.3-0.5 mg IM (0.3-0.5 mL of 1:1000 solution) into the anterolateral aspect of the thigh 1, 3
  • Repeat frequency: Every 5-15 minutes as necessary until symptoms resolve 2, 1
  • Multiple doses: If several doses are required, consider starting an IV infusion (5-15 μg/min) rather than repeated boluses 4, 3

Pediatric Dosing for Anaphylaxis

  • Children ≥30 kg: 0.3-0.5 mg IM (same as adults) 1
  • Children <30 kg: 0.01 mg/kg IM (0.01 mL/kg of 1:1000), maximum 0.3 mg 1, 2
  • Age-based dosing:
    • 12 years: 500 μg (0.5 mL of 1:1000) 3

    • 6-12 years: 300 μg (0.3 mL of 1:1000) 3
    • <6 years: 150 μg (0.15 mL of 1:1000) 3

IV Administration for Severe Anaphylaxis

Only use IV epinephrine when the patient has established IV access and is in anaphylactic shock with severe hypotension or bronchospasm. 4, 3

  • Dose: 0.05-0.1 mg (5-10% of cardiac arrest dose) using 1:10,000 concentration 2
  • Initial bolus in monitored setting: 50 μg (0.5 mL of 1:10,000) for adults, repeatable as needed 3
  • Continuous infusion: 5-15 μg/min for refractory cases 4

Cardiac Arrest Management

Standard-dose epinephrine (1 mg IV/IO every 3-5 minutes) remains the evidence-based approach for cardiac arrest, as it improves return of spontaneous circulation compared to placebo. 2, 5

Adult Cardiac Arrest Dosing

  • Standard dose: 1 mg IV/IO every 3-5 minutes using 1:10,000 (0.1 mg/mL) concentration 2
  • Route: Intravenous or intraosseous 2
  • Timing: Administer as early as possible; delays beyond 20 minutes are associated with worse neurological outcomes 6

Pediatric Cardiac Arrest Dosing

  • Initial dose: 0.01 mg/kg (0.1 mL/kg of 1:10,000) IV/IO every 3-5 minutes 2
  • Refractory arrest: Consider higher doses of 0.1-0.2 mg/kg of 1:1000 concentration 2

Special Consideration: Anaphylaxis Progressing to Cardiac Arrest

If anaphylaxis causes cardiac arrest, immediately switch to cardiac arrest dosing protocols (1 mg IV/IO every 3-5 minutes for adults, 0.01 mg/kg for children), as standard resuscitative measures take priority over anaphylaxis-specific dosing. 2

Critical Safety Considerations

Preventing Fatal Dosing Errors

A major safety concern is the 10-fold overdose that occurs when cardiac arrest doses (1 mg IV) are mistakenly given to anaphylaxis patients. This error causes severe systolic dysfunction, ventricular arrhythmias, and potentially lethal cardiac complications. 7

  • Stock prefilled IM syringes: Hospitals should maintain clearly labeled, prefilled intramuscular epinephrine syringes (1:1000) that are visually distinct from IV formulations (1:10,000) 2, 7
  • Concentration awareness: 1:1000 (1 mg/mL) is for IM use in anaphylaxis; 1:10,000 (0.1 mg/mL) is for IV use in cardiac arrest 1, 7

Administration Technique

  • Never inject into: Buttocks, digits, hands, or feet due to risk of tissue necrosis 1
  • Preferred site: Anterolateral thigh for IM injections 1, 2
  • If extravasation occurs: Infiltrate the site with phentolamine to prevent tissue necrosis 2

High-Risk Populations

Exercise caution in patients with underlying cardiovascular disease, hyperthyroidism, Parkinson's disease, diabetes, and pheochromocytoma, as they are at greater risk for adverse reactions including ventricular arrhythmias, angina, and hypertensive crisis. 1

Adjunctive Therapy for Anaphylaxis

After epinephrine administration, provide supportive care:

  • Fluid resuscitation: Aggressive IV crystalloid (0.9% saline or lactated Ringer's) at high rates, as up to 37% of circulating volume may be lost 3, 4
  • Antihistamines: Chlorphenamine 10 mg IV (adult dose) 3
  • Corticosteroids: Hydrocortisone 200 mg IV (adult dose) 3
  • Persistent bronchospasm: IV salbutamol infusion, consider aminophylline or magnesium sulfate 3

Note: Antihistamines, beta-agonists, and corticosteroids have no proven benefit during cardiac arrest from anaphylaxis and should not delay epinephrine or resuscitation. 4

Monitoring and Follow-up

  • Close hemodynamic monitoring is essential, especially in anaphylactic shock, as cardiovascular and respiratory status can change rapidly 2, 4
  • Mast cell tryptase levels: Obtain blood samples at presentation, 1-2 hours after symptom onset, and at 24 hours or during convalescence to confirm anaphylaxis 3
  • Airway management: When anaphylaxis causes obstructive airway edema, rapid advanced airway management is critical 4

References

Guideline

Pediatric Adrenaline Dosing Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Anafilaxia y Choque Anafiláctico

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Adrenaline dosage during cardiopulmonary resuscitation: a critical review.

European journal of emergency medicine : official journal of the European Society for Emergency Medicine, 1994

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.